MM-398 (liposomal irinotecan)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for MM-398 (liposomal irinotecan), covering 2016-02-12 to 2016-02-12. Get the full timeline:
Most recent: Clinical Trial Update: Study of MM-398 With or Without 5-FU/LV, Versus 5-FU/LV in Patients With Metastatic Pancreatic Cancer [Phase 3]